Company development

Eye-drops have been our competence for more than 70 years and still are.
The eye tonic “Augentonikum Stulln” was Stulln’s first pharmaceutical product, this being followed by successive innovations over the following decades.

After erecting a new building in 2002 and investing in several additional extensions, production started in 2015 with a fully automatic production and conditioning line.

In 2021 a further packaging line has started operations and construction of a new warehouse and laboratory building has begun.
These will be finished and put on operation at the end of 2022 and beginning of 2023.

This consistent expansion has set the course for further growth and successful development.